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Abstract
Background: Genome-wide expression signatures are emerging as potential marker for overall survival and disease
recurrence risk as evidenced by recent commercialization of gene expression based biomarkers in breast cancer.
Similar predictions have recently been carried out using genome-wide copy number alterations and microRNAs.
Existing software packages for microarray data analysis provide functions to define expression-based survival gene
signatures. However, there is no software that can perform survival analysis using SNP array data or draw survival
curves interactively for expression-based sample clusters.
Results: We have developed the survival analysis module in the dChip software that performs survival analysis
across the genome for gene expression and copy number microarray data. Built on the current dChip software’s
microarray analysis functions such as chromosome display and clustering, the new survival functions include
interactive exploring of Kaplan-Meier (K-M) plots using expression or copy number data, computing survival p-
values from the log-rank test and Cox models, and using permutation to identify significant chromosome regions
associated with survival.
Conclusions: The dChip survival module provides user-friendly way to perform survival analysis and visualize the
results in the context of genes and cytobands. It requires no coding expertise and only minimal learning curve for
thousands of existing dChip users. The implementation in Visual C++ also enables fast computation. The software
and demonstration data are freely available at http://dchip-surv.chenglilab.org.
Background
In cancer clinical practice, predicting patient survival
based on traditional tumor staging systems using clinical,
histopathological and molecular markers remains
an integral component in the treatment decision for
patients. For example, patients with advanced disease and
poor survival prognosis are subjected to more aggressive
treatments. However, this conventional approach is non-
specific and has limited success in the cancer treatment.
Many patients have recurrence despite having aggressive
therapy based on survival risk score [1,2].
With high-throughput cancer genomics data, we and
others have reported using genome-wide expression sig-
natures to predict survival risk, and these signatures are
now increasingly being used in treatment decision for
several cancer types [3-6]. Survival predictions have also
been carried out using genome-wide copy number altera-
tions [7,8] and microRNAs [9,10]. Encouraged by these
results, researchers routinely analyze large sets of micro-
array data in relation to survival information. Common
analysis tasks and endpoints include gene signatures that
predict survival risk, survival difference between sample
groups defined by unsupervised clustering, and survival
analysis using the copy-number data of local genomic
regions. Such survival analysis on a high-dimensional
data requires statistical programming and command-line
skills, or the use of the existing software packages such as
BRB-ArrayTools, Survival Online tool and Prediction
Analysis for Microarrays (PAM) [11-13].
However, there is no specific utility that can perform
survival analysis using SNP array data or draw survival
curves interactively for expression-based sample clusters.
We have developed the widely-used dChip software that
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copy number data from microarray datasets (http://www.
dchip.org) [14,15], and have pioneered using SNP arrays
to find chromosomal alterations such as amplification,
deletion, and loss of heterozygosity (LOH) [16]. Thus, the
addition of survival functions will be helpful for research-
ers to query and correlate chromosomal regions of inter-
est with associated survival data.
Here, we describe the survival analysis module in the
dChip software that performs survival analysis across
the genome for gene expression and copy number
microarray data. The new survival functions include
interactive exploring of Kaplan-Meier (K-M) plots using
both expression and copy number data, computing sur-
vival p-values from the log-rank test and Cox models,
and using permutation to assess the survival significance
of copy numbers genome-wide. Researchers can also
compare survival curves between sample clustering
groups derived from expression data. The dChip survival
module enables user-friendly, interactive survival analy-
sis and visualization of microarray data in the context of
genes and cytobands. It requires no need for coding and
minimal learning curve for existing dChip users. The
implementation in Visual C++ also enables fast compu-
tation for processing large data sets from studies such as
the Cancer Genome Atlas (TCGA).
Implementation and analysis examples
The survival analysis functions are implemented in dChip
using Visual C++ and optimized for fast computation.
The computed log-rank test and Cox model statistics and
p-values are confirmed using R code. Figure 1 sum-
marizes the preliminary raw data analysis and new work-
flow functions in two categories. a) those for SNP copy
number data, and b) those for expression-based sample
clustering groups.
Example data sets
Here we will use two example data sets to demonstrate
the functions: 1) performing survival analysis using SNP
data, and 2) drawing K-M plots using expression-based
sample clustering groups. For the first dataset [7], we
will discuss the following dChip analysis steps: SNP data
input and normalization, plotting copy number data in
the chromosome view, carrying out survival analysis
using the log-rank and Cox model, and the permutation
function to adjust for multiple testing and assess the
genome-wide significance of the survival scores. For the
second dataset, we will use a gene expression dataset
consisting of 170 uniformly treated patients with multi-
ple myeloma with clinical follow-up of more than five
years (Munshi et al., manuscript in preparation). We
will first perform unsupervised hierarchical clustering
and define gene signatures that classify the samples into
sub-groups, and then compare K-M curves by the log-
rank test among these sub-groups.
Preparing an example dataset with survival outcome for
analysis
We will use a 192-sample microarray dataset processed
on Affymetrix SNP 500 K microarray platform [7] to
illustrate the usage of the new analysis and visualization
functions. This data set represents 192 uniformly treated
patients with multiple myeloma (MM). MM is a com-
mon type of hematological cancer and characterized by
malignant clonal transformation of plasma cells in bone
marrow with excess production of a monoclonal immu-
noglobulin. Chromosomal aberrations are a hallmark of
MM with specific changes (del-13 and t(4;14)) giving
poor prognosis and other changes (hyperdiploidy and t
(11;14)) conferring better survival [17].
We use the dChip software to normalize all the arrays
of 192 myeloma samples and additional 10 normal blood
samples to compute model-based signal values. Normali-
zation and model-based signals are calculated for each of
the two sub-arrays and combined. The median genotype
call rates are 96.77% and 97.35% respectively for the 250
K Nsp and Sty sub-arrays. A tab-delimited sample infor-
mation file is prepared with columns specifying survival
outcome including survival time and event indicator (0 =
alive, 1 = death). Numerical columns are marked in the
column header such as “Survival(numeric)”,a n dw i l lb e
standardized and displayed above the samples in the clus-
tering or chromosome data views. After loading the nor-
malized data into dChip using the menu function
“Analysis > Open group“,w eu s et h e“Tools > Array List
File“ menu function to create an array list to order sam-
ples by the values of a particular sample variable. Array
list files are also useful when doing survival analysis on a
subset of samples, leaving other samples out of the down-
stream analysis.
The next step displays the data along chromosomes
using the menu function “Analysis > Chromosome“ to
specify analysis parameters for copy number and LOH
analysis (Figure 2). The copy number analysis functions
are explained in detail in the dChip manual [14]. When
Figure 1 The overview of dChip survival functions for
microarray data. MBEI: model-based expression index.
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Page 2 of 9the ploidy of samples are unknown (i.e. tumor samples),
we can check the option “Scale copy number mode to 2
copy“ to adjust for ploidy effect sample-wise, so that in
hyperdiploid samples the chromosomes with normal
copy numbers are estimated to have two copies rather
than deletion events.
Once the data is displayed by chromosomes, we can
toggle between showing individual and all chromosomes
using the “Chromosome > Show All“ menu. Figure 3
shows the gain and loss of copy numbers in the chro-
mosome view, with SNPs on the rows and samples on
the columns. It also uses an array list file to sort all the
samples by survival time irrespective of the event indica-
tor. We can browse the genome and quickly observe
whether copy gain and loss events are associated with
survival. Figure 3 shows that hyperdiploid samples with
three copies in chromosome 5 tend to locate on the
right side (thus longer survival time) rather than on the
left side, suggesting hyperdiploidy is associated with bet-
ter survival outcome of myeloma patients.
Genome-wide log-rank test using sample groups defined
by SNP copy number
In the first survival analysis function, we use the menu
function “Chromosome > Compute Score“ to perform
genome-wide, single-SNP survival analysis by selecting
the “Survival Log-Rank p-value“ option under “Scoring
method“ (Figure 4). It will perform SNP-wise log-rank
test for association between copy numbers and survival
outcome. The data variables of either event free survival
or overall survival can be selected by clicking “Response
variable“ to open the “Select factors“ dialog (Figure 4).
For a SNP, all the samples are divided into three groups
based on this SNP’s inferred copy number: Deletion (≤
1.5 copy), Gain (≥ 2.5 copy), and “No change” (between
1.5 and 2.5 copy). This copy thresholds are adjustable at
the “Options > Score“ dialog. The log-rank test is then
applied to the three sample groups, testing the null
hypothesis that there is no survival difference between
the groups.
Across the genome, we compute the log-rank test
score for one of every 10 consecutive SNPs to speed up
the computation. This is because the inferred copy
numbers are correlated for nearby SNPs when com-
puted from 10-SNP local median smoothing, leading to
correlated log-rank test scores for nearby SNPs. The
window size of 10 is user-adjustable at the dialog option
“Tools > Options > Score > Use one of every 10 markers“.
Once the log-rank test is applied to all the SNPs, dChip
will display the survival scores genome-wide (Figure 3).
T h eb l u ec u r v eo nt h er i g h td i s p l a y st h en e g a t i v el o g 1 0
transformed p-values from the log-rank test, with larger
values indicating stronger association between copy
numbers and survival outcome. The vertical red line in
Figure 2 The “Analysis > Chromosome” menu dialog and options to view copy number data along chromosome. More description of
the options is at the dChip website (http://www.dchip.org).
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Page 3 of 9the gray box indicates the score threshold for the gen-
ome-wide significance at the 0.05 level by the MaxT
permutation method (see the section below on permuta-
tion). One or more regions across the genome could
have scores exceeding the threshold. Inspecting the
genes within these regions could identify candidate sur-
vival-associated genes (Figure 5).
To draw a Kaplan-Meier plot (K-M plot) for an indivi-
dual SNP, we first click on either a SNP nearby a gene of
interest (the menu function “Chromosome > Find Gene“
can search for genes) or a SNP from the regions with sig-
nificant survival scores. Then, we use the “View > K-M
plot” function to draw a K-M plot using the copy number
data of the SNP to form Deletion, Gain, and “No change”
groups as above (Figure 6). The p-value to test the differ-
ent survival rates between the groups is computed using
the log-rank test when there are two or more groups each
with 5 or more expected number of events. The SNP
(rs16915104) in this K-M plot is within the transcribed
region of the PLEKHA5 (PEPP2), an X-linked human
homeobox gene at chromosome 12p12.3, which encodes
transcription factor with known oncogenic role in cancer
and drug resistance via phosphoinositide-mediated signal
pathways [18,19]. Using this approach, we can first per-
form genome-wide screen of SNPs to locate chromosome
regions of significant log-rank scores, and then zoom into
the peak regions and use K-M plots to check the survival
correlation of the SNPs and genes in the region.
Figure 3 The dChip chromosome view of copy numbers and survival association scores. The SNP copy numbers in all the chromosomes
are displayed in log2 ratios (red for gains and blue for losses), with SNPs on rows ordered by chromosome and positions, and samples on
columns ordered by survival time. Hyperdiploid samples (copy number > 2.5 for a number of chromosomes) tend to locate towards the right,
where samples have longer survival. The first blue curve on the right side is SNP-wise, -log10 transformed p-value from the log-rank test, e.g. 3
correspond to a p-value of 0.001. The second blue curve on the right is the Cox model z-scores. The absolute z-scores are displayed SNP-wise:
the red color for positive and blue color for negative scores. The vertical red lines indicate the genome-wide score threshold at the significance
0.05 level using permutation analysis (log-rank: 5.71; Cox model: 5.31).
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Page 4 of 9Genome-wide Cox regression using SNP copy numbers
The second analysis function performs univariate Cox
regression for survival outcome using the inferred copy
numbers of SNPs. After calculating and displaying the
inferred copy numbers in the chromosome view, we use
the menu function “Chromosome > Compute Score“ and
select the “Survival Cox Regression“ option under “Scor-
ing method“ to perform univariate Cox regression for
individual SNPs across the genome (Figure 4). The com-
puting time will vary depending on the number of sam-
ples and SNPs; it takes less than 10 minutes to process
the 500 K SNP, 192 sample data on a 2.4 GHz CPU
with 3 GB RAM.
This function displays the absolute z-scores com-
puted from the Cox model in the gray box on the
right of the copy number view (Figure 3 and 5). Nega-
tive z-scores are displayed in blue, indicating less
hazard or longer survival as copy number increases:
copy number gains are associated with longer survival,
or copy number deletions are associated with shorter
survival. Positive z-scores are displayed in red, indicat-
ing higher hazard or shorter survivals as copy number
increases. As before, ordering samples based on survi-
val time visualizes and confirms the association
between copy number alteration events and survival
variables. Other continuous or binary sample variables
Figure 4 The “Chromosome > Compute Score” menu dialog for
log-rank analysis and permutation function. (A) The survival
response variables are selected from the data columns in a sample
information file. The event and event-free survival (EFS) variables can
also be selected to perform survival analysis. (B) Additionally, the
“Permutation methods” option provides permuting scheme by
either “Chromosome blocks” or “Clinical variables”.
Figure 5 An enlarged chromosome region. The enlarged chromosome 12 region has significant survival scores (indicated by the red arrow in
Figure 3). The gene names are displayed on the left with bars representing the transcribed region. The Cox z-scores are displayed on the right
as the blue curve. One of the SNP in the gene region of PLEKHA5 is used to draw K-M plot (Figure 6).
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Page 5 of 9can also be selected as “Covariates“ to perform multi-
variate Cox regression to assess the explanatory power
of a SNP’s copy number to survival in the context of
these variables (Figure 4). Permutation can be applied
to determine the genome-wide threshold to call chro-
mosome regions significantly associated with survival
outcome.
Permutation to identify significant chromosome regions
associated with survival
We also extend the existing permutation function in
dChip to assess the genome-wide significance of the sur-
vival scores derived from the log-rank test or Cox
regression. The number of permutation runs is specified
at the “Chromosome > Compute Score“ dialog (Figure 4).
Figure 6 The Kaplan-Meier plot for a SNP, using its copy numbers to group samples. The copy number deletion at SNP_A-1882232
(rs16915104 at chromosome 12p12.3) is associated with poor survival. The chromosome view above the K-M plot shows a score value in the
right-sided gray box, crossing the significant score threshold (red) derived from permutation analysis. Also, the neighboring SNPs are showing
similar survival scores. These SNPs are in the transcribed region of gene PLEKHA5 (PEPP2) - a known oncogenic transcription factor (see text for
details). The legend for each sample group shows the number of samples, the Expected events (Exp), and the Observed events (Obs).
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benefits from computing for only a subset of SNPs
across the genome.
The permutation tests the null hypothesis that there
is no chromosome region in the cancer genome whose
copy number is associated with survival, and therefore
any observed association is due to random chance. To
simulate data sets under the null hypothesis, we can
either permute survival times with censoring indicators
across samples or permute chromosome region blocks
within every sample. The survival scores from the
simulated data sets are then compared to those from
the original data set. Specifically for permuting chro-
mosome region blocks, for each sample, whose SNPs
are ordered first by chromosomes and then by posi-
tions within chromosome, we randomly partition the
whole genome into K (≥ 2) blocks, and randomly
switch the order of these blocks while preserving the
order of SNPs within each block. In this way, the SNPs
and their copy numbers in a sample are randomly
relocated in blocks to new positions in the genome,
while only minimally perturbing the dependence of the
copy number data of neighboring SNPs. The same per-
mutation applies to all samples using a different ran-
dom partition for each sample. The survival score at
each SNP locus can then be computed for the per-
muted data set, and the MaxT method can be applied
to assess the significance of the original scores [20].
The maximal survival scores from every permuted data
set form the score distribution, whose 95
th largest
value is the genome-wide threshold at the 0.05 signifi-
cance level to determine the chromosome regions sig-
nificantly associated with survival in the original
dataset. Similarly, clinical variables such as survival
times and censoring indicators can be permuted
together among all the samples and this achieves simi-
lar genome-wide significance threshold (Additional file
1: Figure S1 and Additional file 2: Figure S2).
Kaplan-Meier plots for expression-based sample
clustering groups
Unsupervised hierarchical clustering is frequently used
to discover novel sample sub-groups from microarray
data or inspect the expression-based samples clusters in
relation to clinical variables. In particular, it is interest-
ing to know whether sample clusters correspond to dif-
ferential survival outcomes.
We develop a third analysis function in dChip to
facilitate drawing K-M plots based on sample clusters.
We first use the “Analysis > ANOVA & Correlation“
menu to specify the survival variable and event indica-
tor, similar to Figure 4. Next, we use “Analysis > Clus-
tering & Enrichment“ menu to cluster samples using a
variation-filtered gene list. Interested in whether
sample clusters correspond to different survival out-
comes, we can click to select a main sample cluster
branch (in blue color) and use Control-click to select
and color additional sample clusters (Figure 7A). We
then use the menu “View/K-M Plot“ to display the
Kaplan-Meier plot and log-rank p-value based on the
specified sample clusters (Figure 7B). The dChip Ana-
lysis View will also show the details of log-rank test
and the number of samples omitted due to missing
survival data.
Discussion and conclusions
Gene expression changes and copy-number alterations
are known to influence cancer progression and patient
survival. Currently, the survival analysis of genome-wide
copy number data using SNP arrays and the assessment
of significance requires specialized statistical software
and skills. We have developed the survival analysis mod-
ule within the dChip software to streamline the survival
analysis and interactive visualization of SNP copy num-
ber data and expression-based sample clusters. We use
data analysis examples to show how dChip can interac-
tively explore K-M plots and find survival associated
genomic regions of interest. The easy user-interface and
fast computing make these dChip functions accessible
to biomedical researchers.
Survival analysis using copy number data provides
options to use either the log-rank test or Cox regression
model to compute survival association. The genome-
wide view after both analysis methods displays a side-
curve showing survival scores for consecutive SNPs. The
results from the dChip survival functions agree with
previously published results on the same dataset [7].
The amplifications in chromosome 1q and deletions in
1p and 16q are associated with poor survival, whereas
the copy number gain of chromosomes 5 and 11 pre-
dicts a good prognosis.
We can change the size of SNP window for copy-
number smoothing from the default 10 SNPs to other
numbers. Increasing the window size will speed up the
computation when sample size is large. But we need to
be cautious that large window sizes may miss potential
survival association of SNPs, especially those SNPs near
or within the gene coding regions.
Unsupervised hierarchical clustering is a standard
approach to analyzing expression profiling. Researchers
are often interested in whether samples clusters corre-
spond to different event-free survival, overall survival,
or treatment response outcomes. We have also devel-
oped functions in dChip to draw sample cluster-based
K-M plots. A user can select two or multiple cluster
nodes to compute, display, and export high-quality
survival figures. To our knowledge, few software
packages provide such graphical interface to ease the
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Page 7 of 9survival analysis without coding. We find Survival
O n l i n e( S O )t o o lb yC o r r a d ie ta l .[ 1 2 ]au s e f u lo n l i n e
portal for Cox regression and survival analysis using
gene expression data. At present, dChipSurv provides
similar analysis for SNP array data. Together, these
two applications will provide complementary set of
features to users in need of survival analysis using
expression and copy-number microarray data.
In summary, the dChip survival module addresses
the frequent need of many researchers to integrate
survival data analysis under a single microarray analy-
sis package with minimal learning curve, fast
computing, and no requirement of programming skills.
We will add more survival functions as well as extend
them to microRNA and RNA-seq data in future dChip
versions.
Availability and requirements
Project name: dChip survival analysis module
Project home page: http://dchip-surv.chenglilab.org/
Operating system(s): Windows 2000 or after
Programming language: Visual C++ 2005
Source code: Available on request.
License: The software is freely available.
Figure 7 The Kaplan-Meier survival plots from expression-based sample clusters. (A) In the sample clustering view from the “Analysis >
Clustering & Enrichment” function, we can click and select sample clusters of interest for making K-M plots. The blue and red clusters are selected
and highlighted. (B) The K-M plot is drawn by the “View > K-M plot“ function. The legend for each sample group shows the number of samples,
the Observed events (Obs) and the Expected events (Exp).
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